A sharp 9.5% drop in Navitas stock greeted Wednesday’s news that semiconductor rival Wolfspeed has initiated a patent infringement lawsuit. Shares tumbled to $12.72 as markets reacted to allegations targeting the company’s core technology, though the firm remains up 78% since the beginning of the year.
Shareholders of New York-based professional services firm Marsh are set for a pay increase, as the board of directors authorized a 10% hike to the company's quarterly dividend. The adjustment pushes the payout from 90 cents to 99 cents per share, reflecting a broader strategy to return capital to investors.
Investors reacted sharply to FreeCast’s latest capital raise, sending the media platform’s share price down 9.7% to $3.16 in Wednesday morning trading. The decline marks a deepening trend for the stock, which has shed 22% of its value over the last three months following the announcement of the $23.7 million private placement.
Farmers and independent mechanics will soon gain broader access to diagnostic software, ending a long-standing legal battle over monopolistic repair practices. Deere announced a settlement with the Federal Trade Commission and five states on Wednesday, signaling a significant shift in how the manufacturer manages its agricultural equipment service ecosystem.
Lyft is set to acquire the Spanish bikeshare operations of Serveo, a move that marks the rideshare giant’s first foray into managing public bike networks on both sides of the Atlantic. The deal transitions Lyft from a technology provider to the primary operator for systems across seven major Spanish cities.
Military strikes have effectively shuttered the Strait of Hormuz, sending crude prices climbing more than $5 per barrel on Wednesday. The volatility follows President Trump’s declaration that a cease-fire deal with Iran has collapsed, raising immediate concerns over a protracted energy crisis as tanker traffic grinds to a halt.
Investors are bracing for a test of PepsiCo’s recovery strategy as the snack and soda giant prepares to report second-quarter results Thursday. Analysts expect a profit of $2.99 billion on $23.95 billion in sales, yet recent market performance suggests deep-seated skepticism regarding the company's ability to regain momentum.
Frontier Group is shedding a portion of its incoming fleet, striking a deal to sell 11 Airbus A321neo aircraft to Avolon Leasing Ireland 3. The agreement, finalized late last month, marks a strategic pivot for the carrier as it recalibrates its expansion plans to prioritize higher operational productivity.
Geopolitical instability is reshaping the pharmaceutical supply chain as Evonik Industries moves to secure its footprint in the American Midwest. The German specialty chemicals firm announced a $100 million capital infusion to modernize its Lafayette, Indiana facility, aiming to capture the rising demand for domestic contract manufacturing services.
Chevron has finalized a technology-licensing deal with ZL Chemicals, granting the supply firm rights to commercialize proprietary surfactants designed for unconventional reservoirs. This partnership aims to scale the oil giant's chemical recovery methods, transitioning them from laboratory development into turnkey field services for shale and tight-oil operators.
Shares of Satellos Bioscience climbed 16% to $9.49 following positive clinical results for SAT-3247, an experimental treatment for Duchenne muscular dystrophy. The company’s stock has now gained 61% since January, reflecting growing investor confidence in its approach to degenerative muscle disease therapy.
Investors pushed FuelCell Energy shares down 13% on Wednesday following news that the company upsized its public offering to $225 million. The stock, which hit $22.60 in recent trading, is recalibrating after a meteoric 328% surge over the past year, as the market digests the influx of 10.7 million new shares.
An arbitration tribunal has cleared the path for Prime Medicine to advance its PM647 treatment for alpha-1 antitrypsin deficiency, ruling the drug falls squarely within the company's rights under its 2019 agreement with Beam Therapeutics. The decision shields Prime from potential claims and clears a critical regulatory hurdle for the firm.
Unexpectedly reversing an eleven-week trend of consistent declines, U.S. crude oil stockpiles climbed by 3 million barrels for the week ending July 3. The Energy Information Administration reported that inventory levels reached 411.4 million barrels, defying analyst expectations of a 1.4 million barrel draw during the same period.
A renewed escalation in the Strait of Hormuz has sent travel stocks into a tailspin, with major U.S. airlines and cruise operators shedding between 1% and 3% in early morning trading after President Trump declared the fragile ceasefire with Tehran officially dead.
As Clarke moves to integrate a significant commercial real estate portfolio, the Canadian firm has overhauled its executive team, elevating finance chief Tom Casey to the role of president. The move signals a strategic shift to sharpen operational oversight across the company’s diverse residential, hotel, and commercial real estate holdings.
The Department of Veterans Affairs has awarded CACI International a six-year, $308 million contract to overhaul its aging financial infrastructure. The defense contractor will transition the agency’s legacy systems to a modernized enterprise resource planning platform designed to streamline accounting, procurement, and reporting processes across the federal department.
Endeavour Silver reported a 31% increase in consolidated silver production to 1.94 million ounces for the second quarter, yet the company fell short of its internal output targets. The growth was largely driven by contributions from the Kolpa mine, offsetting significant operational declines at its long-standing Mexican assets.
A 5.6% jump in premarket trading greeted Palladyne AI on Wednesday as the defense and industrial technology firm reported a sharp increase in preliminary quarterly revenue. The stock, which had already climbed 26% year-to-date, responded to figures that significantly outpaced the expectations set by Wall Street analysts.
Four completed drill holes have already confirmed mineralization, prompting IsoEnergy to resume its summer exploration campaign at the Larocque East uranium project. The Canadian firm mobilized its team back to the eastern Athabasca Basin site this week, moving past a brief evacuation triggered by encroaching northern Saskatchewan wildfires.
Brent crude futures spiked 5% to $73.93 a barrel Wednesday after President Trump signaled the collapse of the mid-June ceasefire with Iran. Speaking at a NATO summit in Ankara, Trump dismissed ongoing diplomatic efforts, labeling Iranian leadership as dishonest while citing renewed vessel attacks in the Strait of Hormuz.
The U.S. Food and Drug Administration is reviewing Arcutis Biotherapeutics’ application to expand the use of its Zoryve topical cream to infants as young as three months old. The agency has set a target action date of February 23, 2027, for the treatment of mild to moderate atopic dermatitis.
Canadian Prime Minister Mark Carney committed on Wednesday to provide a detailed roadmap for national defense financing in this autumn’s budget update. Speaking from Ankara during a NATO summit, Carney faced mounting pressure to explain how Ottawa will fund an ambitious military buildup, including a massive new submarine acquisition.
Shares of Douglas Elliman tumbled 12% to $1.71 in premarket trading Wednesday as the real estate firm announced a sweeping digital overhaul. The company plans to consolidate its workflows under a new intelligence-focused subsidiary named Elius, aiming to reclaim data control and modernize operations through a partnership with Google Cloud.
The Canadian military is moving to secure its northern frontier, reaching an agreement in principle for Telesat’s Lightspeed satellite network to provide protected Ka-band communications across the Arctic. This strategic initiative aims to modernize defense capabilities as the country pushes to meet long-term NATO spending benchmarks.
Critical Metals has appointed advisors to conduct a comprehensive strategic review of its portfolio, signaling an aggressive pivot toward its Tanbreez rare earth project in Greenland. The company is actively weighing asset sales, spin-offs, and joint ventures to streamline operations and unlock value from its non-core holdings.
Consumer products firm Helen of Troy posted a $35.8 million net profit for the first quarter, a sharp reversal from the massive $450.7 million loss reported during the same period last year. The results, fueled by growth in both its Home and Outdoor and Beauty and Wellness segments, easily outpaced analyst projections.
Dallas-based energy firm HF Sinclair has elevated Steven Ledbetter to president and chief operating officer, marking a significant step in the company’s efforts to stabilize its executive suite following a turbulent spring that saw the departure of its top leadership team.
A sweeping leadership shuffle at Ovid Therapeutics has placed Charles Carter in the role of chief financial officer, signaling a shift in the biopharmaceutical firm’s internal structure as it looks toward its next phase of development. The changes involve multiple internal promotions and a strategic new hire.
International Medication Systems, a subsidiary of Amphastar Pharmaceuticals, faces federal scrutiny following a warning letter from the Food and Drug Administration. The agency identified specific violations of current good manufacturing practices at the company’s South El Monte, California plant, prompting an immediate internal remediation effort from the firm.
